Tekla Capital Management’s Biohaven BHVN Stock Holding History

Tekla Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,087	Closed	-$479K	–	171
2023 Q1	$479K	Hold	35,087	–	–	0.02%	151
2022 Q4	$487K	Buy	+35,087	New	+$495K	0.02%	149

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Tekla Capital Management's BHVN Position: Q2 2023 in Review

Tekla Capital Management sold out of Biohaven (BHVN) in Q2 2023, closing a stake of 35,087 shares — an estimated $479K sold.

Tekla Capital Management first reported a position in BHVN in Q4 2022 and held it in 2 quarters. The position peaked at $487K in Q4 2022. 188 funds tracked by Wall St. Rank hold BHVN as of Q2 2023.

Tekla Capital Management reported no remaining Biohaven position as of Q2 2023 after selling out during the quarter.
Tekla Capital Management sold 35,087 Biohaven shares in Q2 2023, an estimated $479K.
Tekla Capital Management first reported a position in Biohaven in Q4 2022 and held it in 2 quarters.
Tekla Capital Management's Biohaven position peaked at $487K in Q4 2022.
188 funds tracked by Wall St. Rank held Biohaven as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.